James Ficorilli

1.7k total citations
20 papers, 1.3k citations indexed

About

James Ficorilli is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, James Ficorilli has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 12 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in James Ficorilli's work include Diabetes Treatment and Management (9 papers), Pancreatic function and diabetes (9 papers) and Receptor Mechanisms and Signaling (6 papers). James Ficorilli is often cited by papers focused on Diabetes Treatment and Management (9 papers), Pancreatic function and diabetes (9 papers) and Receptor Mechanisms and Signaling (6 papers). James Ficorilli collaborates with scholars based in United States, Australia and Canada. James Ficorilli's co-authors include David J. Hauss, Laura F. Michael, Tapon Roy, James J. Keirns, Kyle W. Sloop, Michael E. Christe, Thomas P. Burris, Aaron D. Showalter, Kelli Bramlett and Todd Cook and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Diabetes.

In The Last Decade

James Ficorilli

20 papers receiving 1.2k citations

Peers

James Ficorilli
Margaret van Heek United States
Douglas S. Compton United Kingdom
Kang Cheng United States
Bryan F. Burkey United States
Natalia Mast United States
James Ficorilli
Citations per year, relative to James Ficorilli James Ficorilli (= 1×) peers Tamihide Matsunaga

Countries citing papers authored by James Ficorilli

Since Specialization
Citations

This map shows the geographic impact of James Ficorilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Ficorilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Ficorilli more than expected).

Fields of papers citing papers by James Ficorilli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Ficorilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Ficorilli. The network helps show where James Ficorilli may publish in the future.

Co-authorship network of co-authors of James Ficorilli

This figure shows the co-authorship network connecting the top 25 collaborators of James Ficorilli. A scholar is included among the top collaborators of James Ficorilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Ficorilli. James Ficorilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabrera, Over, James Ficorilli, Janice Shaw, et al.. (2021). Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon. Journal of Biological Chemistry. 298(2). 101484–101484. 23 indexed citations
2.
Coşkun, Tamer, Julie S. Moyers, William C. Roell, et al.. (2021). 679-P: The Novel GIP, GLP-1, and Glucagon Triple Receptor Agonist LY3437943 Exhibits Robust Efficacy in Preclinical Models of Obesity and Diabetes. Diabetes. 70(Supplement_1). 9 indexed citations
3.
Bueno, Ana B., Bingfa Sun, Francis S. Willard, et al.. (2020). Structural insights into probe-dependent positive allosterism of the GLP-1 receptor. Nature Chemical Biology. 16(10). 1105–1110. 69 indexed citations
4.
Ma, Wenzhen, Xingjuan Chen, Rok Cerne, et al.. (2018). Catechol estrogens stimulate insulin secretion in pancreatic β-cells via activation of the transient receptor potential A1 (TRPA1) channel. Journal of Biological Chemistry. 294(8). 2935–5880. 18 indexed citations
5.
Bueno, Ana B., Aaron D. Showalter, David B. Wainscott, et al.. (2016). Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles. Journal of Biological Chemistry. 291(20). 10700–10715. 48 indexed citations
6.
Garibay, Darline, Anne K. McGavigan, Seon A Lee, et al.. (2016). β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy. Endocrinology. 157(9). 3405–3409. 49 indexed citations
7.
Jun, Lucy S., Aaron D. Showalter, Feihan F. Dai, et al.. (2014). A Novel Humanized GLP-1 Receptor Model Enables Both Affinity Purification and Cre-LoxP Deletion of the Receptor. PLoS ONE. 9(4). e93746–e93746. 25 indexed citations
8.
Syed, Samreen K., Lisa S. Beavers, James T. Alston, et al.. (2013). Ectonucleotidase NTPDase3 is abundant in pancreatic β-cells and regulates glucose-induced insulin secretion. American Journal of Physiology-Endocrinology and Metabolism. 305(10). E1319–E1326. 22 indexed citations
9.
Willard, Francis S., Denise Wootten, Aaron D. Showalter, et al.. (2012). Small Molecule Allosteric Modulation of the Glucagon-Like Peptide-1 Receptor Enhances the Insulinotropic Effect of Oxyntomodulin. Molecular Pharmacology. 82(6). 1066–1073. 44 indexed citations
10.
Wootten, Denise, Emilia E. Savage, Céline Valant, et al.. (2012). Allosteric Modulation of Endogenous Metabolites as an Avenue for Drug Discovery. Molecular Pharmacology. 82(2). 281–290. 61 indexed citations
11.
Syed, Samreen K., Hai H. Bui, Lisa S. Beavers, et al.. (2012). Regulation of GPR119 receptor activity with endocannabinoid-like lipids. American Journal of Physiology-Endocrinology and Metabolism. 303(12). E1469–E1478. 107 indexed citations
12.
Tersey, Sarah A., Takeshi Ogihara, Dhananjay Gupta, et al.. (2010). Inhibition of Deoxyhypusine Synthase Enhances Islet β Cell Function and Survival in the Setting of Endoplasmic Reticulum Stress and Type 2 Diabetes. Journal of Biological Chemistry. 285(51). 39943–39952. 34 indexed citations
13.
Sloop, Kyle W., Francis S. Willard, Martin Brenner, et al.. (2010). Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets. Diabetes. 59(12). 3099–3107. 121 indexed citations
14.
Schmidt, Robert J., James Ficorilli, Youyan Zhang, et al.. (2006). A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity. Journal of Lipid Research. 47(5). 1037–1044. 14 indexed citations
15.
Chouinard, Michael, Amy L. Cox, James Ficorilli, et al.. (2006). Farnesoid X Receptor Agonist Reduces Serum Asymmetric Dimethylarginine Levels through Hepatic Dimethylarginine Dimethylaminohydrolase-1 Gene Regulation. Journal of Biological Chemistry. 281(52). 39831–39838. 73 indexed citations
16.
Foxworthy, Patricia, Angela M. Siesky, James Ficorilli, et al.. (2005). Hepatic Peroxisomal Fatty Acid β-Oxidation Is Regulated by Liver X Receptor α. Endocrinology. 146(12). 5380–5387. 40 indexed citations
17.
Stayrook, Keith R., Kelli Bramlett, Rajesh S. Savkur, et al.. (2004). Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor. Endocrinology. 146(3). 984–991. 238 indexed citations
18.
Hauss, David J., et al.. (1998). Lipid-Based Delivery Systems for Improving the Bioavailability and Lymphatic Transport of a Poorly Water-Soluble LTB4 Inhibitor. Journal of Pharmaceutical Sciences. 87(2). 164–169. 263 indexed citations
19.
Johnson, Michael P., Nelson L. Velayo, Carrie G. Markgraf, et al.. (1998). MDL 101,002, a free radical spin trap, is efficacious in permanent and transient focal ischemia models. Life Sciences. 63(4). 241–253. 11 indexed citations
20.
Hauss, David J., et al.. (1998). Chronic Collection of Mesenteric Lymph From Conscious, Tethered Rats.. PubMed. 37(3). 56–58. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026